Essity published comparative financial figures on December 2, 2025, ahead of introducing four business areas on January 1, 2026: Health & Medical, Personal Care, Consumer Tissue and Professional Hygiene. These replace the previous three-area structure. Healthcare incontinence products, including TENA, belong to Health & Medical; retail incontinence products, also including TENA, belong to Personal Care alongside feminine care and baby care. Essity will first report under the new structure in its first-quarter 2026 results.
The pro forma information covers 2023, 2024 and the first nine months of 2025, restating sales, organic growth, margins, EBITA, capital employed, return on capital employed and operating cash flow. For January–September 2025, group net sales were SEK 103,799 million. Healthcare incontinence accounted for 12% of group sales and retail incontinence for 8%. These are category shares within Essity's sales. Including their other categories, Health & Medical represented 20% and Personal Care 23%; Consumer Tissue represented 31% and Professional Hygiene 26%.